Nuclear Medicine physician, theranostics specialist and researcher @MSKCancerCenter. Tweets and views are my own.
Joined October 2009
- Tweets 39
- Following 102
- Followers 389
- Likes 170
1 Photos and videos
Lisa Bodei, MD, PhD retweeted
19 Mar 2025
Green nuclear medicine and theranostics: debate and discussion. ow.ly/pMGa50VgahK
#NuclearMedicine #Theranostics #MolecularImaging @ProfKHerrmann
6
16
1,310
Lisa Bodei, MD, PhD retweeted
28 Feb 2025
Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually). ow.ly/T40950UYrU2
#RPTherapy #NuclearMedicine #Theranostics @CalaisJeremie @lisabodei @CzerninJohannes
5
11
683
Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2, the first trial to examine radioligand therapy as a first-line therapy for cancers. Full episode here: youtu.be/whHhKf5fY8I
1
7
23
1,927
Lisa Bodei, MD, PhD retweeted
15 Dec 2023
The hard copies of "Radiopharmaceutical Therapy" have arrived! Managed to get a pic with my Co-Editors…. The book really is the perfect stocking filler @lisabodei @TheZeglisLab
3
7
56
3,321
20 Nov 2023
Thank you, Jason!!! Such a fantastic endeavor! Without you and Brian it would never have been possible
20 Nov 2023
It’s out!!! A huge thank you to all the contributors. Such a pleasure doing this with Professors @lisabodei and @TheZeglisLab. This book covers amazing the field of radiopharmaceutical therapy and is a real page turner. The perfect stocking filler 😀 doi.org/10.1007/978-3-031-39…
2
10
1,506
1 Jul 2023
Coming in the fall 2023. So proud to have been a part of this fantastic endeavor! Everything about RPT. @LewisLabMSKCC @TheZeglisLab
30 Jun 2023
Coming to a bookstore near you in the Fall 2023. A super comprehensive guide to RPT. @lisabodei @TheZeglisLab
7
52
2,558
Lisa Bodei, MD, PhD retweeted
24 Jun 2023
We will also have a tumor board focused on clinical applications of PSMA-targeted radioligand therapy. What an amazing panel including @morr316 @lisabodei @TubaKendi @CalaisJeremie. See what people think of cases like this. Looking forward to seeing everyone bright and early!
4
20
1,296
New Guideline Alert! Joint #SNMMI #EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks @EANM_NucMed!
ow.ly/g7Ls50OKN8q #NuclearMedicine #RPTherapy #ProstateCancer
23
50
7,359
Lisa Bodei, MD, PhD retweeted
9 Jun 2023
Excited to announce the release of the @SNM_MI consensus statement on PSMA RLT. We attempted to wrangle with a number of difficult questions about how to use PSMA RLT in clinical practice. Check it out at: jnm.snmjournals.org/content/…
2
28
92
10,372
Lisa Bodei, MD, PhD retweeted
Amazing Keynote by @lisabodei before tonight’s opening ceremony #ISRS2023
1
6
448
Lisa Bodei, MD, PhD retweeted
Panelists are Dr.(s) Tara Masten, @CaterinaRamogi1, Danielle Vugts, and @lisabodei!
1
3
316
Lisa Bodei, MD, PhD retweeted
16 May 2023
1. For the first @SNMMI_CIC case, @lisabodei from @MSKCancerCenter presents a case of #PSMARLT where FDG PET, post-treatment SPECT and MRI all play a role in understanding response. Please watch the full video at bit.ly/3Bw5kDm.
2
4
14
1,349
Lisa Bodei, MD, PhD retweeted
11 Apr 2023
A study published in @JournalofNucMed and led by @lisabodei and Heiko Schöder found that blood-based biomarkers accurately predict neuroendocrine tumor response to radiopharmaceutical therapy. This study was selected as the featured article of the month: bit.ly/40YblEd
2
10
37
4,920
Lisa Bodei, MD, PhD retweeted
10 Apr 2023
Using blood-based #biomarkers to determine the efficacy of ¹⁷⁷Lu-DOTATATE in #NeuroendocrineTumors. ow.ly/4PAF50NAttU
#NuclearMedicine #MedicalResearch #NETCancer @lisabodei @DianeReidyLagun @LabKrebs @amauguen @DrRichardDo
13
24
3,234